News About: R&D
Sporanox showed the lowest discontinuation rate in therapy
The majority of patients with athlete's foot at toenails tend to discontinue their medication as the treatment period becomes longer, and patient's poor recognition on the necessity of treatment and its period has con...
Anticancer candidate substance RX-0201 likely to be commercialized in 2007
Korean health food maker Rexgene Biotech and Maryland-based Rexahn Corporation in the US, said it made a joint research agreement on RX-0201, a promising anticancer substances, on February 6.
Under the agreement, ...
Industrial development strategies put priority more on prescription drugs.
The domestic pharmaceutical industry put more efforts to the development of prescription drugs rather than OTCs.
The KFDA's drug registration data in 2002 revealed the total 1,166 of product registrations including...
Establishment of new traditional drug R&D center eyed
Chechun City in Chungbuk Province said the establishment of a new traditional drug R&D assistance center by the year 2005 is being promoted in an area of 6,600㎡ within a regional industry complex of Chechun.
For th...
Natural products based patent applications up sharply
The domestic market for natural drugs has been spotlighted as one of the promising industries that may contribute to better competitiveness of local pharmaceutical and biotechnology firms.
The Korea Industrial Prop...
Magnolia extracts to develope for asthma treatment
Magnolia was known as excellent anti-asthmatic effects since long time and its extract has been developed under the code of NDC-052.
The Ministry of Science and Technology announced that NDC-052, the extract from M...
Government to allow 6.0 billion R&D loan in BT sector
The Ministry of Science & Technology has unveiled its massive loan plan for Korea's science and technology promotion fund amounting to a total of 90.0 billion won (general collateral loan: 40.0 billion won, technology...
New drug R&D to set for national core industry.
The government and relevant organizations confirmed their supports for the R&D of new drug discovery while the pharmaceutical industry expressed their enthusiastic wills of expanding the R&D investment at the event of...
Joint Research of Disease DNA for Korean and Mongol
Macrogen has announced that Seo Jung-sun, the president of Macrogen made an agreement with the Public Health Department of Mongol regarding Korea-Mongol joint research of disease DNA on Dec 30, 2002.
According to ...
Acupuncture Effects on Fertility identified in America
Dr. Raymond Chang of Cornell University and Meridian Medical in New York and his research colleagues have discovered that acupuncture can help reduce stress, increase blood flow to the reproductive organs and help nor...
